HBV Mutation Detail Information

> W172* Search Result


Mutation Information
Mutation Site W172*
Mutation Type Amino acid level
Gene/Protein/Region Type S
Combined Mutation s.W172*+rt.A181T
Relevant Drug lamivudine (LAM);adefovir (ADV)
Literature Information
PubMed PMID 18537180
Disease Chronic hepatitis B
Published Year 2008
Journal Hepatology (Baltimore, Md.)
Title The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound.
Author Warner N,Locarnini S
Evidence The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound.

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation